Results 171 to 180 of about 19,083 (252)

Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database. [PDF]

Clin Rheumatol
Bodur H, Ataman Ş, Yurdakul FG, Gürer G, Akgün K, İnceoğlu LA, Sunar İ, Akgül Ö, Sezer İ, Çapkın E, Rezvani A, Yağcı İ, Duruöz MT, Çay HF, Çevik R, Göğüş F, Kamanlı A, Ecesoy H, Güler T, Şahin N, Cengiz G, Melikoğlu MA.   +21 more
europepmc   +1 more source

IgA nephropathy with rheumatoid arthritis related to adalimumab. [PDF]

CEN Case Rep
Tüfekçi B, Kardaş RC, Öğüt B, Erden A.   +3 more
europepmc   +1 more source

Care of the Patient with Interstitial Lung Disease Perioperatively. [PDF]

Curr Rheumatol Rep
Berger K, Braverman G, Siltumens A, Gordon J, Kaner R.   +4 more
europepmc   +1 more source

[Rational use of antirheumatic agents].

Lijecnicki vjesnik, 1983
T, Dürrigl, B, Vrhovac
openaire   +1 more source

Recombinant zoster vaccine in patients with inflammatory rheumatic diseases: efficacy, long-term protection and safety under immunosuppression. [PDF]

RMD Open
Krasselt M.
europepmc   +1 more source

Prompt clinical and electrophysiological remission of refractory peripheral neuropathy in long-standing rheumatoid arthritis with tocilizumab: a case report. [PDF]

Front Immunol
Huang H, Zhong X, Kuang S, Tan J, Tan L, Li B.   +5 more
europepmc   +1 more source

[Treatment of adult chronic non-bacterial osteitis in Germany : Comparison of real-world practice and current expert consensus recommendations]. [PDF]

Z Rheumatol
van Wijnen P, Klemm P, Schmidt M, Christofyllakis K, Müller-Ladner U, Assmann G.   +5 more
europepmc   +1 more source

2. Antirheumatic Agents, 2) Biological Agents

Nihon Naika Gakkai Zasshi, 2012
openaire   +2 more sources

Tofacitinib: New drug in the therapeutic armamentarium in ocular inflammation. [PDF]

Indian J Ophthalmol
Babu K, Mooss V.
europepmc   +1 more source